Agilent Technologies Form 4 shows new RSU grant to senior VP

Rhea-AI Filing Summary

Agilent Technologies, Inc. (A) reported a change in ownership by a senior vice president on a Form 4. On November 18, 2025, the officer received 5,368 shares of common stock through a grant of restricted stock units at a stated price of $0, reflecting an equity award rather than a market purchase. Following this grant, the reporting person beneficially owned 7,043 shares directly.

The restricted stock units were granted under the Agilent Technologies, Inc. 2018 Stock Plan and are scheduled to vest in four equal annual installments beginning on November 18, 2026, meaning the officer will gain full access to the shares over a four-year period if vesting conditions are met.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Henson Meghan

Role Senior Vice President

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	5,368	$0.00	--

Holdings After Transaction: Common Stock — 7,043 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Henson Meghan

(Last) (First) (Middle)

5301 STEVENS CREEK BLVD.

(Street)

SANTA CLARA CA 95051

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AGILENT TECHNOLOGIES, INC. [ A ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Senior Vice President

3. Date of Earliest Transaction (Month/Day/Year)
11/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/18/2025		A		5,368	A	$0(1)	7,043	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted Stock Units granted under the Agilent Technologies, Inc. 2018 Stock Plan, in compliance with Rule 16b-3. The restricted stock units vest in four equal annual installments beginning on November 18, 2026.

	/s/ Bret DiMarco, attorney-in-fact for Ms. Henson	11/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Agilent Technologies (A) disclose in this Form 4 filing?

Agilent Technologies disclosed that a senior vice president received 5,368 shares of common stock via a restricted stock unit grant on November 18, 2025, reported on Form 4.

How many Agilent (A) shares does the reporting person own after this transaction?

After the reported transaction, the senior vice president beneficially owned 7,043 shares of Agilent common stock directly.

What type of award was granted to the Agilent (A) executive?

The executive received restricted stock units granted under the Agilent Technologies, Inc. 2018 Stock Plan, reported as common stock acquired at a stated price of $0.

When do the restricted stock units for the Agilent (A) officer vest?

The restricted stock units vest in four equal annual installments beginning on November 18, 2026.

Is this Agilent (A) Form 4 related to derivative securities such as options or warrants?

The provided tables show activity only in non-derivative common stock, with no derivative securities reported in Table II.

Who signed the Form 4 for the Agilent (A) reporting person?

The Form 4 was signed by /s/ Bret DiMarco, attorney-in-fact for Ms. Henson on November 20, 2025.